Related Experiment Video
Updated: Oct 28, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Recurrent massive pulmonary embolism following catheter directed thrombolysis in a 21-year-old with COVID-19: a case
Julian H Hirschbaum1,2, C Pierce Bradley2, Philip Kingsford2
1Department of Pediatrics, Keck School of Medicine of USC, LAC+USC Med+Peds, IRD Building 2020 Zonal Avenue, Rm 115, Los Angeles, CA 90033, USA.
Insights
This case study details a young, otherwise healthy male who developed massive pulmonary embolism (PE) and recurrent PE following Coronavirus Disease-2019 (COVID-19). Treatment involved catheter-directed thrombolysis and ECMO, highlighting COVID-19
Area of Science:
- Cardiology
- Pulmonology
- Infectious Diseases
Background:
- Coronavirus Disease-2019 (COVID-19) is linked to a higher risk of pulmonary embolism (PE).
- Venous thrombo-embolic (VTE) events can occur even in low-risk individuals with COVID-19.
Observation:
- A 21-year-old male with no prior medical history presented with symptoms of COVID-19 and massive PE.
- The patient experienced recurrent massive PE, acute respiratory failure, and hypotension shortly after initial treatment.
- He required repeat catheter-directed thrombolysis (CDT) and extracorporeal membrane oxygenation (ECMO) for recovery.
Findings:
- Despite extensive testing, no hypercoagulable risk factors were identified apart from COVID-19.
- This case represents the youngest patient reported with massive PE secondary to COVID-19.
- Successful treatment involved CDT and ECMO, facilitating right ventricular recovery.
Implications:
- SARS-CoV-2 infection poses a significant thrombogenic risk, leading to severe complications even in young individuals.
- Catheter-directed thrombolysis and ECMO are viable treatment options for massive PE in COVID-19 patients.
- This case underscores the critical need for vigilance regarding VTE in COVID-19 patients, regardless of age or traditional risk factors.
Background:
Coronavirus Disease-2019 (COVID-19) has been associated with increased incidence of pulmonary embolism (PE), even among patients at low risk for venous thrombo-embolic (VTE) events.
Case Summary:
We present the case of a 21-year-old male, with no previous medical history, who presented with cough, fevers, shortness of breath, pleuritic chest pain, and 1 day of dizziness with near syncope as well as acutely worsened dyspnoea. He was subsequently diagnosed with COVID-19 and massive PE. He underwent successful catheter-directed thrombolysis (CDT), and his clinical status improved. One day following initial CDT, he developed acute respiratory failure and hypotension and was diagnosed with recurrent massive PE. He was treated with repeat CDT and extracorporeal membrane oxygenation (ECMO) to provide time for right ventricular recovery. The patient was able to be weaned off ECMO after 9 days and was eventually extubated and discharged to an acute rehabilitation facility.
Discussion:
Beyond COVID-19, no hypercoagulable risk factors were identified despite thorough investigation. This case highlights the thrombogenic potential and morbid sequelae of SARS-CoV-2 infection, even in young patients. It also highlights the use of CDT and ECMO among patients with massive PE and COVID-19. To date, this is the youngest reported patient to develop massive PE in the setting of COVID-19.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management
Venous Thrombosis III: Interprofessional Care
Pneumothorax-II
Clinical Manifestations:
Venous Thrombosis I: Introduction

